Enliven Therapeutics, Inc.
2023 Q2 - 2025 Q4 (10 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/26/2026 | 44 | 0.0% | 2,884 | 12/31/2025 |
| 2025 Q3 | 11/3/2025 | 47 | 0.0% | 2,290 | 9/30/2025 |
| 2025 Q2 | 7/21/2025 | 38 | 0.0% | 1,896 | 6/30/2025 |
| 2025 Q1 | 4/24/2025 | 34 | 0.0% | 1,635 | 3/31/2025 |
| 2024 Q4 | 1/27/2025 | 36 | 0.0% | 1,628 | 12/31/2024 |
| 2024 Q3 | 10/23/2024 | 41 | 0.0% | 1,708 | 9/30/2024 |
| 2024 Q2 | 7/30/2024 | 33 | 0.0% | 1,404 | 6/30/2024 |
| 2023 Q4 | 1/24/2024 | 170 | 0.0% | 12,305 | 12/31/2023 |
| 2023 Q3 | 10/26/2023 | 154 | 0.0% | 11,276 | 9/30/2023 |
| 2023 Q2 | 8/10/2023 | 230 | 0.0% | 11,276 | 6/30/2023 |